Product Catalog

MOTS-cSpecifications & Batch COA

Mitochondria-derived peptide that regulates metabolic homeostasis, insulin sensitivity, and immune aging.

KERUIHK-0603MOTS-c product vial
Lyophilized PowderProduct image
Immune & Thymic

MOTS-c

ResearchKERUIHK-0603

Mitochondria-derived peptide that regulates metabolic homeostasis, insulin sensitivity, and immune aging.

Product Specifications

CAS Number
1627580-64-6
Catalog Purity
≥99.03%
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

MOTS-c specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
MOTS-c
Catalog reference
KERUIHK-0603
CAS number
1627580-64-6
Category
Immune & Thymic
Physical form
Lyophilized Powder

Latest reported batch: MOTS-c

Batch PB-2026-MOT-3589 · Oct 26, 2026

Sample specification
10 mg/vial
Reported appearance
White lyophilized powder
Reported molecular weight / identity
2174.60 Da
Analytical method
RP-HPLC (214 nm) / ESI-HRMS
Storage stated in this report
−20°C, protect from light

Reported analytical results

Appearance
Conforms — White lyophilized powder; no visible particulates or cakingReport specification: White to off-white powderMethod: Visual inspection
Solubility
<30 s; clear and colorless; no suspended or undissolved particlesReport specification: Soluble in water (≥5 mg/mL)Method: 2.0 mL sterile water; gentle swirling
HPLC Purity
99.60%Report specification: ≥99.0%Method: SOP-HPLC-MOT-001-v2
Molecular Weight (MS)
2174.60 Da; −9.20 ppmReport specification: 2174.62 Da; within method toleranceMethod: SOP-MS-MOT-002 / ESI-HRMS
Show 5 more test results
Amino Acid Analysis
ConformsReport specification: Conforms to sequence MRWQEMGYIFYPRKLRMethod: AAA / USP <1052>
Water Content (KF)
2.15%Report specification: ≤8.0%Method: Karl Fischer / USP <921>
Residual Solvents
Acetonitrile <80 ppm; Dichloromethane <30 ppm; DMF <50 ppmReport specification: ICH Q3C Class 2Method: GC-HS
Sterility
No microbial growth observedReport specification: No evidence of microbial growthMethod: 14-day sterility test
Endotoxin (LAL)
< 0.20 EU/mgReport specification: < 5.0 EU/mgMethod: USP <85> gel-clot; reporting limit 0.10 EU/mg
Source COA: PB-2026-MOT-3589-R20261026
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-MOT-3589Report product: MOTS-c · 10 mg/vialOct 26, 2026 · Reported purity: 99.60%View this batch COA
PB-2026-MOT-3560Report product: MOTS-cOct 2, 2026 · Reported purity: 99.54%View this batch COA
PB-2026-MOT-3560Report product: MOTS-cAug 28, 2026 · Reported purity: 99.4%View this batch COA
Show 2 earlier reports
PB-2026-MOT-0187Report product: MOTS-cJun 24, 2026 · Reported purity: 99.2%View this batch COA
PB-2026-MOT-0118Report product: MOTS-cApr 26, 2026 · Reported purity: 99.0%View this batch COA

Product Inquiry

Request a MOTS-c quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products